Back to search

Article

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022

2023-04-18

Abstract excerpt

<h4>Background: </h4> This cohort study assessed seroprevalence trends of SARS-CoV-2 antibodies in the general Belgian population between March 2021 and April 2022, and explored factors associated with seropositivity among the vaccinated and unvaccinated population. Seroreversion and its potential determinants were also examined. Methods A random sample of the adult population in Belgium was invited to provide a s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8adbe6d-d9db-58be-8576-d6eb935d924b
DOI
10.21203/rs.3.rs-2802349/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022DOI 10.21203/rs.3.rs-2802349/v1
The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upSemantic proximity
Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, CanadaSemantic proximity
Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort StudySemantic proximity
First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity
Prevalence and Incidence of Antibodies Against Sars-Cov-2 Among Primary Healthcare Providers in Belgium During One Year of the Covid-19 Epidemic: Prospective Cohort Study ProtocolSemantic proximity
ESTIMATING THE INCIDENCE OF SARS-COV-2 INFECTIONS IN 2020 IN BELGIUM BY JOINTLY MODELLING SEROPREVALENCE, HOSPITALIZATION AND MORTALITY DATASemantic proximity
Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic reviewSemantic proximity
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveysSemantic proximity
The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity
SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity
Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity
Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sampleSemantic proximity
Select a neighboring publication to make it the new centre.